Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Preferred Shares Issued (2020)

Historic Preferred Shares Issued for Foghorn Therapeutics (FHTX) over the last 1 years, with Q3 2020 value amounting to $41.9 million.

  • Foghorn Therapeutics' Preferred Shares Issued changed N/A to $41.9 million in Q3 2020 from the same period last year, while for Dec 2021 it was $41.9 million, marking a year-over-year change of. This contributed to the annual value of $89.9 million for FY2020, which is 48755.72% up from last year.
  • Foghorn Therapeutics' Preferred Shares Issued amounted to $41.9 million in Q3 2020.
  • Over the past 5 years, Foghorn Therapeutics' Preferred Shares Issued peaked at $41.9 million during Q3 2020, and registered a low of $41.9 million during Q3 2020.